Dedicated to improving lives
Terumo Heart, Inc. is dedicated to the innovation, introduction and advancement of products to improve the quality of healthcare for heart failure patients.
Our principal focus is the development, clinical evaluation and commercialization of the DuraHeart Left Ventricular Assist System (LVAS).
The DuraHeart system is designed to provide long-term circulatory support and address the shortage of donor hearts for cardiac transplantation. Combining patented magnetic-levitation and centrifugal pump technologies, the DuraHeart’s proprietary blood-friendly design helps decrease complications and improve the lives of patients with severe heart failure.
Terumo Heart, Inc. is a wholly owned subsidiary of Terumo Corporation with headquarters in Ann Arbor, Michigan.
Terumo Heart, Inc. partners with physicians, healthcare professionals, hospitals and patients to deliver superior solutions for treating heart failure. The company strives to ensure that its world-class products, services and professional business practices maintain these principles:
We work to create an environment of cooperation between associates, clinicians and patients by quickly responding to evolving needs and desires.
We work to show respect to all those we encounter and achieve respect from all those we serve.
We care about the well-being of our patients, associates and society as a whole.
We make all efforts to do what we say and maintain the highest levels of quality and reliability.
We uphold the highest standards for honesty and ethics in our communications, behaviors and actions.
We aim to achieve financial strength to support the continual advancement of knowledge and technology to best serve our customers